Edwards Lifesciences Corporation · NYSE:EW

Lippis Daniel J. sold 2,038 Edwards Lifesciences Corporation shares (Form 4)

Traded May 1 to May 4, 2026 · Filed May 4, 2026

From May 1 to May 4, 2026, Lippis Daniel J. (CVP, TAVR) sold 2,038 Edwards Lifesciences Corporation shares at an average US$83.49 for US$170K under a trading plan, leaving 33,682 shares. Filed May 4, 2026 (Form 4).

Sold
2,038 shares
Price
US$83.49 average (US$82.99 to US$83.99)
Value
US$170K
Holding after
33,682 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CVP, TAVR

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockOption exercise1,019US$59.2634,953Direct
May 1, 2026Common StockSale19US$83.9934,934Direct
May 1, 2026Common StockSale1,000US$82.9933,934Direct
May 3, 2026Common StockShares withheld for tax252US$83.9833,682Direct
May 4, 2026Common StockOption exercise1,019US$59.2634,701Direct
May 4, 2026Common StockSale1,019US$83.9833,682Direct

Source

View original at SEC

Related